Skip to content
10-K

Annual Report

20/20 BIOLABS, INC. AIDX

0001213900-26-037667

← back to feed
Filed
Mar 31, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 30, 2026 10.44M sh
Shares Diluted FY 2025 · Dec 31, 2025 4.93M sh
Shares Diluted FY 2025 · Dec 31, 2024 4.8M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$1.92M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$2.6M
Cash And Equivalents FY 2025 · Dec 31, 2025 $1.03M
Cash And Equivalents FY 2025 · Dec 31, 2024 $1.78M
Stockholders Equity FY 2025 · Dec 31, 2025 −$19.23K
Stockholders Equity FY 2025 · Dec 31, 2024 $1.51M
Stockholders Equity FY 2025 · Dec 31, 2023 $4.29M
Current Liabilities FY 2025 · Dec 31, 2025 $2.46M
Current Liabilities FY 2025 · Dec 31, 2024 $1.36M
Total Liabilities FY 2025 · Dec 31, 2025 $4.16M
Total Liabilities FY 2025 · Dec 31, 2024 $2.08M
Current Assets FY 2025 · Dec 31, 2025 $1.47M
Current Assets FY 2025 · Dec 31, 2024 $2.03M
Total Assets FY 2025 · Dec 31, 2025 $4.14M
Total Assets FY 2025 · Dec 31, 2024 $3.58M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.76
Eps Diluted FY 2025 · Dec 31, 2024 −$1.16
Eps Basic FY 2025 · Dec 31, 2025 −$0.76
Eps Basic FY 2025 · Dec 31, 2024 −$1.16
Sga Expense FY 2025 · Dec 31, 2025 $3.34M
Sga Expense FY 2025 · Dec 31, 2024 $4.76M
Rd Expense FY 2025 · Dec 31, 2025 $592.57K
Rd Expense FY 2025 · Dec 31, 2024 $1.26M
Net Income FY 2025 · Dec 31, 2025 −$3.74M
Net Income FY 2025 · Dec 31, 2024 −$5.55M
Operating Income FY 2025 · Dec 31, 2025 −$3.33M
Operating Income FY 2025 · Dec 31, 2024 −$5.68M
Gross Profit FY 2025 · Dec 31, 2025 $604.54K
Gross Profit FY 2025 · Dec 31, 2024 $360.31K
Cost Of Revenue FY 2025 · Dec 31, 2025 $1.44M
Cost Of Revenue FY 2025 · Dec 31, 2024 $1.39M
Revenue FY 2025 · Dec 31, 2025 $2.05M
Revenue FY 2025 · Dec 31, 2024 $1.75M